跳至主要内容
临床试验/NL-OMON20379
NL-OMON20379招募中不适用

Prospective study on the metabolic and linear growth effects of rhGH treatment in children with Kabuki Syndrome.

Maastricht University Medical Centre (MUMC)PO box 58006202 AZ MaastrichtThe Netherlands0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Children with mutation in the KMT2D gene (also known as MLL2) or the KDM6A gene.
  • Children who meet at least four out of five KS characteristics:

排除标准

  • Children with a chronological or bone age greater than 8 years for girls and 10 years for boys, because of the influence of puberty.
  • Extremely low dietary intake (less than minimal required intake for age according to WHO criteria).

研究者

发起方
Maastricht University Medical Centre (MUMC)PO box 58006202 AZ MaastrichtThe Netherlands

相似试验